IDEA Pharma | From R&D to RxD Email Format
Business Consulting and ServicesEngland, United Kingdom11-50 Employees
IDEA Pharma is a pharmaceutical strategy consultancy that operates as a division of SAI MedPartners and serves clients globally. It specializes in guiding the path from research and development to market, applying design-thinking approaches early in development to generate options that are clinically and commercially viable. The firm is based in London, with additional offices in the United Kingdom and New York City. IDEA Pharma's services include strategic positioning, portfolio and disease-area strategy, value proposition development, scenario planning and strategy stress testing, and communications strategy. Its approach centers on developing design options that address clinical, regulatory, and market-access hurdles, recognizing that multiple factors—such as indication, patient population, line of therapy, and trial endpoints—can influence a medicine's path to market. In March 2026, IDEA Pharma announced that a campfire session addressing drug development was accepted for presentation at the ECNP Congress 2026 in Munich, illustrating ongoing engagement with the broader scientific community.